---
title: 'Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative
  review.'
authors: "['Rafa\u0142Marecki', 'JoannaKa\u0142uska', 'AgataKolanek', 'DominikaHaka\u0142\
  o', 'NapoleonWaszkiewicz']"
journal: Frontiers in psychiatry
publication_date: ''
doi: 10.3389/fpsyt.2023.1298359
pmid: ''
document_type: review
source: PubMed
search_category: pmdd_mechanisms
search_query: PMDD genetic factors
tags:
- pmdd
- clinical_research
- pathophysiology
- genetics
- premenstrual_dysphoric_disorder
- neuroimaging
- hormones_endocrine
created_date: '2025-10-21'
content_type: research_paper
condition: pmdd
topic: premenstrual_dysphoric_disorder
---

# Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review.

## Authors
['RafałMarecki', 'JoannaKałuska', 'AgataKolanek', 'DominikaHakało', 'NapoleonWaszkiewicz']

## Journal
Frontiers in psychiatry

## Publication Information
- **Year**: 
- **DOI**: 10.3389/fpsyt.2023.1298359
- **PMID**: 

## Abstract
With each passing year, the number of people suffering from mental disorders grows at a disturbing speed. Neuroactive steroids are a new promising group of drugs with the potential for use in many diseases like postpartum depression, postnatal psychosis, major depression, insomnia, bipolar disorder, and Parkinson's tremor, due to their ability to modulate the activity of GABA

## Keywords
pmdd, clinical_research, pathophysiology, genetics, premenstrual_dysphoric_disorder, neuroimaging, hormones_endocrine

## Source Information
- **Source**: PubMed
- **Search Category**: pmdd_mechanisms
- **Search Query**: PMDD genetic factors

---
*This document was automatically processed from PubMed and added to the PMDD research knowledge base.*
